A boring email a day will keep the doctor away, as this saying probably goes for pharma marketers. What makes an HCP really listen to your marketing message? Is it the wow-effect? Variety of channels? Availability? Repetition? As a matter of fact, it’s all of the above and it’s called multichannel engagement.

It turns out that emails not only have the potential to be as sophisticated as to appeal and inform efficiently – but are actually succeeding! The trick is to know what emails HCPs will never mark as junk. Pharma has all chances to engage, and here’s a bundle of best practices currently in the industry.

Thanks to the recent technological boom – pharma industry has already adopted new cross channel approaches. Moreover, multichannel strategy implementation already led to tremendous opportunities for collaborative work and the ability to align all the channels into one robust mix.

The smartest of pharma managers and executives have already been striving to acquire Veeva expertise – but not by wasting too much effort on the goal. It turns out, they are right to feel optimistic! Here’s what exactly can be done to ensure more ease, transparency and confidence.

The fact is just too well-known: if a company wants to become a winner – new rules of engaging multiple emerging local markets should be followed. Only those who are willing to take smart risks, be flexible, innovative, and turn challenges over into their favor will attain remarkable outcomes.